Biomarkers in Samples From Patients With Endometrial Cancer
Learn more about:
Related Clinical Trial
Feasibility Study: IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer) Intervention
Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study
Scalable Communication Modalities for Returning Genetic Research Results
Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
Prostate Cancer Genetic Risk Evaluation and Screening Study
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Evaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome.
DNA Adductomics for Colorectal Cancer Investigation
PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
Faecal Microbiota Characterization in Lynch Syndrome (LS) Patients With or Without Colorectal Neoplasia
Evaluating the Cologuard Test for Use in Lynch Syndrome
PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Identifying and Caring for Individuals With Inherited Cancer Syndrome
Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Direct Information to At-risk Relatives
Family History Study on Cancer Risk
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Biomarkers in Samples From Patients With Endometrial Cancer
Genetic Risk: Whether, When, and How to Tell Adolescents
Familial Colorectal Cancer Registry in Hispanics
Prostate Cancer Screening Among Men With High Risk Genetic Predisposition
Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Identifying Patients With Hereditary and Familial Colorectal Cancer by Using an Online Risk Tool
Pediatric Reporting of Adult-Onset Genomic Results
Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants
MSI in Circulatory DNA of Endometrial Cancer
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Implementation of a New Strategy to Identify HNPCC Patients
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
The GEOLynch Cohort Study
Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome
Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer
Ohio Colorectal Cancer Prevention Initiative
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
I-Scan For Colon Polyp Detection In HNPCC
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
Molecular Screening for Lynch Syndrome in Denmark
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer
Uncertain Genetic Test Results for Lynch Syndrome
High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome.
Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)
Hereditary Nonpolyposis Colorectal Cancer in Taiwan-Related Genetic Study and Clinical Applications
Molecular Screening for Lynch Syndrome in Southern Denmark
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
Multi-Organ Screening Recommendations in Patients With Lynch Syndrome
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria
Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome
Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
Registry for Women Who Are At Risk Or May Have Lynch Syndrome
Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting